PACS
PACS Group, Inc. · Healthcare · Medical - Care Facilities
Momentum-inputs (vergelijkbare managers):
breedte van houders +9.1% ·
aandelenstroom -4.7% ·
netto nieuwe posities +8.3%
— formule
Versnippering van eigendom — meer houders, kleinere totale positie
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q1 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 92 | +6 | 32.30M | $1.38B | +8 | −2 |
| Q1 2026 | 89 | +3 | 29.37M | $943.57M | +9 | −6 |
| Q4 2025 | 86 | +1 | 29.12M | $1.12B | +1 | — |
| Q3 2025 | 18 | +1 | 20.54M | $282.02M | +1 | −1 |
| Q2 2025 | 15 | 0 | 21.01M | $271.39M | +2 | −2 |
| Q1 2025 | 12 | +1 | 9.60M | $107.95M | +2 | −1 |
| Q4 2024 | 11 | -2 | 10.08M | $132.14M | +2 | −4 |
| Q3 2024 | 12 | +1 | 9.71M | $388.06M | +1 | — |
| Q2 2024 | 11 | — | 6.66M | $196.56M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 6.04M | -3.4% | $67.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Wellington Management ✦ | 6.04M | -3.4% | $67.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 3 | Wellington Management ✦ | 6.04M | -3.4% | $67.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Wellington Management ✦ | 6.04M | -3.4% | $67.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Wellington Management ✦ | 6.04M | -3.4% | $67.91M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passief) | 939.42K | +1.3% | $10.56M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | Millennium Management ✦ | 859.29K | +68.3% | $9.66M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 8 | Geode Capital Management ✦ (passief) | 854.08K | +4.2% | $9.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passief) | 854.08K | +4.2% | $9.60M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 343.48K | -54.8% | $3.86M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Marshall Wace ✦ | 214.88K | Nieuw | $2.42M | 0.0% | New | 1 | SEC ↗ |
| 12 | Marshall Wace ✦ | 214.88K | Nieuw | $2.42M | 0.0% | New | 1 | SEC ↗ |
| 13 | Point72 Asset Management ✦ | 178.58K | Nieuw | $2.01M | 0.0% | New | 1 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 61.07K | -72.2% | $686,427 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 61.07K | -72.2% | $686,427 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 45.44K | -37.1% | $510,791 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | D. E. Shaw & Co. ✦ | 33.10K | -38.2% | $372,078 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 17.05K | +9.8% | $192,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Norges Bank ✦ (passief) | 15.52K | -96.4% | $174,490 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $2.42M | 0.0% |
| Marshall Wace | $2.42M | 0.0% |
| Point72 Asset Management | $2.01M | 0.0% |
Verlaten
| Adage Capital Partners | $131,100 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 1 houders, 9.10K aandelen, $292 gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer, Director, 10% owner · 27.59K aand · $1.22M
Officer, Director, 10% owner · 31.65K aand · $1.38M
Officer, Director, 10% owner · 13.88K aand · $621,259
Officer, Director, 10% owner · 77.43K aand · $3.39M
Officer, Director, 10% owner · 84.65K aand · $3.75M
Officer, Director, 10% owner · 67 aand · $3,005
Officer, Director, 10% owner · 66.80K aand · $2.95M
Officer, Director, 10% owner · 74.84K aand · $3.31M
Officer, Director, 10% owner · 9.76K aand · $422,927
Officer · 3.62K aand · $161,421
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie